Amplification of POP1 and RPP29 was frequently observed, such as in ovarian epithelial tumors and endometrial cancer; these RNase P subunits may have particular roles in the promotion of tumorigenesis and could subsequently be developed as potential prognostic markers. The gene discussed is POP1; the disease is endometrial cancer.